This episode explores hypnotics and sedatives as agents that lower arousal thresholds rather than induce unconsciousness. We examine how these drugs interact with inhibitory systems—particularly GABAergic signalling—to quiet hyperactive networks, facilitate sleep, and reduce anxiety. Framed this way, their benefits and risks become predictable: sedation…

This episode examines drugs used in central nervous system degenerative disorders through a lens of preservation rather than reversal. Conditions such as Parkinson’s disease, Alzheimer’s disease, and related syndromes reflect progressive loss of neurons and network integrity. Pharmacology here is about buying time, restoring functional balance, and redu…

Episode description (with key takeaways)This episode explores antiseizure pharmacology as the art of stabilising excitable networks. Seizures arise when synchronous firing overwhelms inhibitory control; treatment therefore focuses on shifting thresholds, damping propagation, and restoring balance between excitation and inhibition. We move beyond drug li…

This episode examines the pharmacological treatment of psychosis and mania as an exercise in regulation rather than suppression. Antipsychotics and mood stabilisers act on systems that assign meaning, importance, and momentum to thoughts and experiences. We move beyond dopamine reduction as a slogan to understand why these drugs work, why they take time…

This episode examines the pharmacological treatment of depression and anxiety through the lens of adaptation and balance. Rather than viewing these conditions as simple chemical deficits, we explore how sustained modulation of neurotransmitter systems gradually recalibrates circuits involved in mood, threat perception, sleep, and cognition. The delayed …

This episode widens the lens from individual synapses to whole neural networks. Central nervous system neurotransmission is less about linear pathways and more about integration—multiple signals converging, diverging, and being reshaped in real time. We explore how excitation and inhibition are balanced, how plasticity changes responses over time, and w…

Episode description (with key takeaways)This episode explores serotonin and dopamine as systems of context rather than single functions. Together, they influence mood, motivation, reward, perception, and movement. We move past simplistic labels (“happy chemical”, “pleasure pathway”) to understand distributed circuits, receptor diversity, and downstream …

Episode description (with key takeaways)This episode explores adrenergic pharmacology as the language of speed and force in human physiology. Adrenaline and noradrenaline drive rapid cardiovascular, respiratory, and metabolic adjustments, preparing the body for demand. We move beyond memorising α and β receptors to understand adrenergic drugs as tools f…

This episode examines nicotinic receptor pharmacology at two critical crossroads: autonomic ganglia and the neuromuscular junction. Here, signalling is rapid, decisive, and threshold-dependent—very different from the modulatory tone of muscarinic systems. We explore how drugs that act at nicotinic receptors can stimulate, block, or exhaust transmission,…

This episode focuses on anticholinesterase agents as a distinctive pharmacological strategy: rather than stimulating receptors directly, these drugs extend the life of an endogenous signal. By inhibiting acetylcholinesterase, they increase acetylcholine availability at synapses and neuromuscular junctions, sharpening or overwhelming physiological effect…